Walgreens Boots Alliance (NASDAQ:WBA) Cut to “Sell” at Deutsche Bank Aktiengesellschaft

Walgreens Boots Alliance (NASDAQ:WBA) was downgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating in a research note issued on Friday, MarketBeat Ratings reports. They currently have a $9.00 price target on the pharmacy operator’s stock, down from their previous price target of $11.00. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential downside of 19.86% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the company. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Bank of America lifted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday. Finally, Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Stock Up 1.7 %

WBA stock opened at $11.23 on Friday. Walgreens Boots Alliance has a 52 week low of $8.08 and a 52 week high of $22.05. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The firm has a 50-day simple moving average of $10.48 and a 200-day simple moving average of $9.72. The stock has a market capitalization of $9.70 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the business posted $0.66 earnings per share. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities analysts forecast that Walgreens Boots Alliance will post 1.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. First Financial Corp IN lifted its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after acquiring an additional 1,590 shares during the period. Colonial Trust Co SC raised its stake in shares of Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,297 shares in the last quarter. Finally, Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.